Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2792 Target Snapshot

Retinoic acid receptor alpha · SINGLE PROTEIN · Mus musculus

116Compounds
22Assays
5Approved Drugs
64.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P11416. Use UniProt P11416 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P11416 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Retinoic acid receptor alpha as ChEMBL target CHEMBL2792, mapped to UniProt P11416. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Retinoic acid receptor alpha
SINGLE PROTEIN · Mus musculus
As of 2026-09-13
ChEMBL target ID
CHEMBL2792
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P11416
Retinoic acid receptor alpha
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Retinoic acid receptor alpha is the right protein anchor across sources, using UniProt P11416 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelRetinoic acid receptor alpha
UniProt AccessionP11416
Component TypeProtein
Sequence Length462 aa

Retinoic acid receptor alpha

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Retinoic acid receptor alpha, mapped to UniProt P11416. Sequence length is 462 aa.

Mapped IDP11416
Review nameRetinoic acid receptor alpha
OrganismMus musculus
Clinical Profile

Clinical Phase Distribution

5
Approved
Assay Mix

Activity Type Distribution

IC5027.0
EC5029.0
KD8.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL38 8.92 EC50 1.2 Approved
CHEMBL4572914 8.4 EC50 4.0 Preclinical
CHEMBL38 8.3 IC50 5.0 Approved
CHEMBL705 8.15 Kd 7.0 Approved
CHEMBL333032 8.1 IC50 8.0 Preclinical
CHEMBL345298 8.04 EC50 9.2 Preclinical
CHEMBL46398 7.96 IC50 11.0 Preclinical
CHEMBL38 7.82 Kd 15.0 Approved
CHEMBL4449668 7.8 EC50 16.0 Preclinical
CHEMBL44478 7.75 EC50 18.0 Preclinical
Distribution

pChEMBL Value Distribution

4
5.0
1
5.5
7
6.0
2
6.5
10
7.0
16
7.5
7
8.0
2
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

ALITRETINOIN
CHEMBL705
Approved 1999
TRETINOIN
CHEMBL38
Approved 1971
Assay Landscape

Assay Landscape

22
Total Assays
41
Tested Compounds
2
Assay Types
Binding — 19 assays, 41 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 10 24 7.5
single protein format 9 17 7.0
Functional — 3 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 2 0
cell-based format 1 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine